Contact UsCompany ProfileHome
Send Inquiry Send SMS    Call Me Free
UNITED BIOTECH Banner
Home » Products » Anticancer Medicines » Cefepime Injection IP 1.0g

Cefepime Injection IP 1.0g

Cefepime Injection IP 1.0g
Cefepime Injection IP 1.0g
Send Inquiry
Product Code : 203
Price And Quantity
  • Minimum Order Quantity
  • 3000
  • Unit of Measure
  • Piece/Pieces
  • Price
  • 10 Onwards INR
Product Specifications
  • Drug Type
  • Drug Solutions
  • Physical Form
  • Liquid
  • Function
  • Anti-Bacterial
  • Dosage
  • 1.0 g
  • Suitable For
  • Adults
Product Description

Cefepime Injection IP 2.0g


Product

Adult dose

Pediatric dose

Adjustment in Renal / Hepatic Impaired patients

Epime

Min / Max IV Dose : 1-2g every 12 hourly for 8 to 12 days. Min / Max IM Dose: 0.5 -1g evey 12 hourly

2 months upto 16 yrs. Of age-50 mg/kg/dose every 8-12hrs.

Yes


Product name

Composition

Indication/s

Strengths

Packing

Epime

Cefepime

Bacteremia, Pneumonia, Febrile Neutroperia, cUTI including pyelonephritis, SSTI, cIAI

1g

1 Vial


Product name

Storage

Stability after reconstitution

Prep of solution

Diluent

Epime (Cefepime 1g, 2g, 500mg & 250 mg Vial)

Store at room temperature at 2º 25ºC & protect from light.

IV/IM Solution : 24 hours when stored at room temperature of 20-25ºC or for 7daywhen refrigerated at 2-8ºC.

IV Infusion : 1 g Vial reconstituted with 10 ml sterile water / 0.9% Dextrose / 0.9% NaCl . IM: 1g Vial reconstituted with 2.4ml Sterile Water / 5% Dextrose / 0.9% NaCl.

Sterile Water, 0.9 % Dextrose, 0.9% NaCl, 5% Dextrose


Trade Information
  • Payment Terms
  • Telegraphic Transfer (T/T)
  • Supply Ability
  • 3000 Per Day
  • Delivery Time
  • 1 Week
  • Sample Available
  • Yes
  • Sample Policy
  • Free samples are available
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • Main Domestic Market
  • All India

UNITED BIOTECH (P) LTD.
X


UNITED BIOTECH (P) LTD. All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.